抄録
<jats:p>HIV-1 infection and its progression to AIDS remains a significant global health challenge, particularly for low-income countries. Developing a vaccine to prevent HIV-1 infections has proven to be immensely challenging with complex biological acquisition and infection, unforeseen clinical trial disappointments, and funding issues. This paper discusses important landmarks of progress in HIV-1 vaccine development, various vaccine strategies, and clinical trials.</jats:p>
収録刊行物
-
- Vaccines
-
Vaccines 9 (9), 1026-, 2021-09-16
MDPI AG
